Loading clinical trials...

Effect of Birth on Immunological Parameters in Cord Blood | Clinical Trials | Clareo Health

COMPLETEDNCT03134768

Effect of Birth on Immunological Parameters in Cord Blood

The purpose of the study is to understand the immediate effect of birth on immunological parameters in vaginally born cord blood.

Lead sponsor: Danone Asia Pacific Holdings Pte, Ltd.•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

TERMINATEDPhase 1

Pain, Opioids and Pro-Inflammatory Immune Responses

NCT01210066 · Pro-inflammatory Activity, Immunologic Activity Alteration

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 3, 2020Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment50

Start dateMay 2016

Last updatedApr 3, 2020

Condition

Immunologic Activity Alteration

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 3, 2020Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions